https://www.indianpharmapost.com/moderna-begins-phase-2-study-of-omicron-specific-bivalent-booster-115792022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/strides-receives-usfda-approval-for-colchicine-tablets-115882022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/first-in-human-trial-in-us-for-gan-lee-type-2-diabetes-drug-115872022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/cancer-surgeons-gather-in-delhi-to-learn-new-cancer-therapies-115862022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvies-phase-3-data-of-atogepant-indicates-positive-outcome-for-migraine-treatment-115852022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/emmes-acquires-casimir-its-fourth-major-acquisition-115842022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/aurobindo-pharma-trains-its-managers-to-be-future-ready-115832022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/amity-awards-dr-azad-moopen-doctorate-for-philanthropy-115822022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/daiichi-sankyo-commits-us-1-million-humanitarian-aid-to-ukraine-115812022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-and-gedeon-richter-to-collaborate-on-neuropsychiatric-diseases-115802022-03-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-lupins-vigabatrin-oral-solution-115892022-03-11T00:00:00+05:30always0.9